MicroPort NeuroTech Engages in Strategic Wealth Management Subscription

An announcement from MicroPort NeuroTech Limited ( (HK:2172) ) is now available.

MicroPort NeuroTech Limited announced that its subsidiary, MP NeuroTech Shanghai, has subscribed to a series of wealth management products with an aggregate outstanding principal amount of RMB240 million, using its cash surplus. This transaction, classified as a discloseable transaction under Hong Kong’s Listing Rules, is structured as a three-month deposit with SPD Bank, offering an expected annualized return rate ranging from 0.85% to 2.34%. The move is part of the company’s treasury management strategy and does not impact its working capital or operations, potentially enhancing its financial positioning without affecting its core business activities.

More about MicroPort NeuroTech Limited

MicroPort NeuroTech Limited, incorporated in the Cayman Islands, is primarily engaged in the research, development, manufacture, and sale of innovative neuro-interventional medical devices. Its wholly-owned subsidiary, MP NeuroTech Shanghai, operates within the People’s Republic of China with a similar focus on neuro-interventional solutions.

Average Trading Volume: 5,506,542

Technical Sentiment Signal: Buy

Current Market Cap: HK$6.14B

For detailed information about 2172 stock, go to TipRanks’ Stock Analysis page.